F-group (family)
208.1.1.4 Hexapep,Hexapep_2
Ligands and drugs
463
Member domains
146
with ligand contacts (≤ 4 Å)
31.5% of members
111
with DrugDomain annotations
24.0% of members
63
with a DrugBank compound
13.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 208.1.1.4 belongs to X-group 208 Single-stranded left-handed beta-helix, which binds 8.7 ligand superclasses per 20 proteins, broader than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01992 | COA | Coenzyme A | 28 |
| DB03462 | TDR | Thymine | 11 |
| DB03556 | PE5 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | 6 |
| DB03435 | UDP | Uridine-5'-Diphosphate | 5 |
| DB03685 | U5P | Uridine monophosphate | 5 |
| DB00133 | SER | Serine | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 46 |
| MGmetal | MAGNESIUM ION | 43 |
| COA | COENZYME A | 32 |
| NAmetal | SODIUM ION | 24 |
| ACO | ACETYL COENZYME *A | 19 |
| CAmetal | CALCIUM ION | 17 |
| TDR | THYMINE | 11 |
| MJZ | (2S,3S,4R,5R,6R)-5-(acetylamino)-4-amino-6-{[(R)-{[(R)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-3-hydroxytetrahydro-2H-pyran-2-carboxylic acid | 6 |
| PE5 | 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL | 6 |
| CDmetal | CADMIUM ION | 5 |
| U5P | URIDINE-5'-MONOPHOSPHATE | 5 |
| UDP | URIDINE-5'-DIPHOSPHATE | 5 |
| NImetal | NICKEL (II) ION | 4 |
| CL | CHLORIDE ION | 3 |
| COO | CROTONYL COENZYME A | 3 |
| PAP | 3'-PHOSPHATE-ADENOSINE-5'-DIPHOSPHATE | 2 |
| SER | SERINE | 2 |
| T3F | (3R,4S,5R,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl][hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate | 2 |
| T3Q | [(3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl][hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate | 2 |
| 5NG | [[(2~{S},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3~{R})-4-[[3-[2-[2-[3-[[(2~{R})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyldisulfanyl]ethylamino]-3-oxidanylidene-propyl]amino]-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-butyl] hydrogen phosphate | 1 |